[Correlation study between carotid atherosclerosis and hypertension]

Nan Li1, Guan-Yi Zheng, Guang-wen Li

  • 1Department of Traditional Chinese Medicine, Fujian Medical University Union Hospital, Fuzhou 350001.

Insights

Hypertension is linked to carotid atherosclerosis (CAS), particularly in patients with phlegm-stasis syndrome (PSS). These patients show a higher incidence of soft plaque, suggesting increased risk for conditions like cerebral infarction.

Area of Science:

  • Vascular Biology
  • Cardiology
  • Traditional Chinese Medicine

Background:

  • Hypertension is a significant risk factor for cardiovascular diseases.
  • Carotid atherosclerosis (CAS) is a major cause of stroke.
  • Phlegm-stasis syndrome (PSS) is a concept in Traditional Chinese Medicine often associated with circulatory issues.

Purpose of the Study:

  • To investigate the relationship between carotid atherosclerosis and hypertension.
  • To compare CAS occurrence and characteristics in hypertensive patients with and without phlegm-stasis syndrome (PSS).

Main Methods:

  • Color Doppler ultrasonography was used to assess CAS in 150 hypertensive patients (70 PSS, 80 non-PSS) and 30 controls.
  • CAS incidence and plaque characteristics (hard vs. soft plaque) were compared across the three groups.
  • Vascular parameters of the carotid arteries were measured.

Main Results:

  • CAS incidence was significantly higher in both hypertensive groups (PSS and non-PSS) compared to controls (P<0.01).
  • The PSS group exhibited a higher incidence of CAS than the non-PSS group (P<0.05).
  • The PSS group showed a significantly higher ratio of soft plaque (41.9%) compared to the non-PSS group (11.4%, P<0.05).
  • Hypertensive groups displayed increased inner diameters and resistance indices in carotid and vertebral arteries compared to controls (P<0.05).

Conclusions:

  • Hypertension is frequently associated with varying degrees of carotid atherosclerosis.
  • Patients with hypertension and PSS have a higher proportion of soft plaque, indicating a potentially elevated risk of target organ damage, such as cerebral infarction.
  • These findings highlight the importance of assessing CAS in hypertensive patients, especially those with PSS.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...